Cargando…

Recombinant protein TRAIL-Mu3 enhances the antitumor effects in pancreatic cancer cells by strengthening the apoptotic signaling pathway

Pancreatic cancer is a highly malignant type of cancer and its treatment remains a major challenge. The novel recombinant protein TNF-related apoptosis-inducing ligand (TRAIL)-Mu3 has been shown to exert stronger tumor inhibitory effects in colon cancer in vitro and in vivo compared with TRAIL. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Min, Yi, Cheng, Huang, Xian-Zhou, Yan, Juan, Wei, Li-Jia, Tang, Wei-Ju, Chen, Shou-Chun, Huang, Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8045166/ https://www.ncbi.nlm.nih.gov/pubmed/33868476 http://dx.doi.org/10.3892/ol.2021.12699

Ejemplares similares

TRAIL mutant membrane penetrating peptide alike-MuR6-TR enhances the antitumor effects of TRAIL in pancreatic carcinoma both in vitro and in vivo
por: Sun, Lei, et al.
Publicado: (2017)

Antitumor Activity of TRAIL Recombinant Adenovirus in Human Malignant Glioma Cells
por: Kim, Ki-Uk, et al.
Publicado: (2005)

Impact of Extracellular pH on Apoptotic and Non-Apoptotic TRAIL-Induced Signaling in Pancreatic Ductal Adenocarcinoma Cells
por: Hagelund, Sofie, et al.
Publicado: (2022)

Endogenous TRAIL-R4 critically impacts apoptotic and non-apoptotic TRAIL-induced signaling in cancer cells
por: Rambow, Anna-Christina, et al.
Publicado: (2022)

IFN-γ-Secreting-Mesenchymal Stem Cells Exert an Antitumor Effect In Vivo via the TRAIL Pathway
por: Yang, Xinyuan, et al.
Publicado: (2014)

Improved antitumor activity of TRAIL fusion protein via formation of self-assembling nanoparticle
por: Huang, Kaizong, et al.
Publicado: (2017)

Pro-apoptotic effect of TRAIL-transfected endothelial progenitor cells on glioma cells
por: Deng, Xin, et al.
Publicado: (2018)

Synergistic antitumor effects of CDK inhibitor SNS-032 and an oncolytic adenovirus co-expressing TRAIL and Smac in pancreatic cancer
por: Ge, Yun, et al.
Publicado: (2017)

TRAIL-R1-Targeted CAR-T Cells Exhibit Dual Antitumor Efficacy
por: Nai, Yaru, et al.
Publicado: (2021)

Hetero-modification of TRAIL trimer for improved drug delivery and in vivo antitumor activities
por: Pan, Li-Qiang, et al.
Publicado: (2015)

TRAIL-Based Therapies Efficacy in Pediatric Bone Tumors Models Is Modulated by TRAIL Non-Apoptotic Pathway Activation via RIPK1 Recruitment
por: Brion, Régis, et al.
Publicado: (2022)

Aloperine executes antitumor effects against multiple myeloma through dual apoptotic mechanisms
por: Wang, He, et al.
Publicado: (2015)

E3 ubiquitin ligases and deubiquitinases as modulators of TRAIL-mediated extrinsic apoptotic signaling pathway
por: Woo, Seon Min, et al.
Publicado: (2019)

Impact of p53 status on TRAIL-mediated apoptotic and non-apoptotic signaling in cancer cells
por: Willms, Anna, et al.
Publicado: (2019)

The tumor suppressive effect and apoptotic mechanism of TRAIL gene‐containing recombinant NDV in TRAIL‐resistant colorectal cancer HT‐29 cells and TRAIL‐nonresistant HCT116 cells, with each cell bearing a mouse model
por: Jung, Bo‐Kyoung, et al.
Publicado: (2023)

Persistent Inhibition of ABL Tyrosine Kinase Causes Enhanced Apoptotic Response to TRAIL and Disrupts the Pro-Apoptotic Effect of Chloroquine
por: Sridevi, Priya, et al.
Publicado: (2013)

Apoptotic pathways in pancreatic ductal adenocarcinoma
por: Hamacher, Rainer, et al.
Publicado: (2008)

TRAIL-β and TRAIL-γ: two novel splice variants of the human TNF-related apoptosis-inducing ligand (TRAIL) without apoptotic potential
por: Krieg, A, et al.
Publicado: (2003)

Enhancing the antitumor activity of an engineered TRAIL-coated oncolytic adenovirus for treating acute myeloid leukemia
por: Wang, Zixuan, et al.
Publicado: (2020)

Synergistic antitumor effects of circularly permuted TRAIL with doxorubicin in triple-negative breast cancer: Circularly permuted TRAIL with Dox in TNBC
por: Liu, Jia, et al.
Publicado: (2023)

Antitumor effects of traditional Chinese medicine targeting the cellular apoptotic pathway
por: Xu, Huanli, et al.
Publicado: (2015)

Annexin V-TRAIL fusion protein is a more sensitive and potent apoptotic inducer for cancer therapy
por: Qiu, Fan, et al.
Publicado: (2013)

Improvement of Pharmacokinetic Profile of TRAIL via Trimer-Tag Enhances its Antitumor Activity in vivo
por: Liu, Haipeng, et al.
Publicado: (2017)

The regulation of combined treatment-induced cell death with recombinant TRAIL and bortezomib through TRAIL signaling in TRAIL-resistant cells
por: Ryu, Sunhyo, et al.
Publicado: (2018)

Activation of systemic antitumor immunity via TRAIL-induced apoptosis
por: James, Britnie R., et al.
Publicado: (2012)

TRAIL is involved in CpG ODN-mediated anti-apoptotic signals
por: LIM, EUN-JUNG, et al.
Publicado: (2011)

Antitumor Effect of Periplocin in TRAIL-Resistant Human Hepatocellular Carcinoma Cells through Downregulation of IAPs
por: Cheng, Chieh-Fang, et al.
Publicado: (2013)

TROP2-directed nanobody-drug conjugate elicited potent antitumor effect in pancreatic cancer
por: Xu, Caili, et al.
Publicado: (2023)

TRAIL-R2-specific antibodies and recombinant TRAIL can synergise to kill cancer cells
por: Tuthill, Mark H, et al.
Publicado: (2014)

Enhanced Antitumor Efficacy of Gemcitabine by Evodiamine on Pancreatic Cancer via Regulating PI3K/Akt Pathway
por: Wei, Wei-Tian, et al.
Publicado: (2011)

Author Correction: Improvement of Pharmacokinetic Profile of TRAIL via Trimer-Tag Enhances its Antitumor Activity in vivo
por: Liu, Haipeng, et al.
Publicado: (2018)

Shikonin potentiates paclitaxel antitumor efficacy in esophageal cancer cells via the apoptotic pathway
por: Du, Wenzhen, et al.
Publicado: (2019)

Reduction of Decoy Receptor 3 Enhances TRAIL-Mediated Apoptosis in Pancreatic Cancer
por: Wang, Wei, et al.
Publicado: (2013)

CD95L Inhibition Impacts Gemcitabine-Mediated Effects and Non-Apoptotic Signaling of TNF-α and TRAIL in Pancreatic Tumor Cells
por: Rashid, Khalid, et al.
Publicado: (2021)

Engineered adenovirus fiber shaft fusion homotrimer of soluble TRAIL with enhanced stability and antitumor activity
por: Yan, J, et al.
Publicado: (2016)

Recombinant trail: a synergistic effect in myeloid leukemias
por: Carvalho, Filipa, et al.
Publicado: (2010)

Oxaliplatin Enhances the Apoptotic Effect of Mesenchymal Stem Cells, Delivering Soluble TRAIL in Chemoresistant Colorectal Cancer
por: Quiroz-Reyes, Adriana G, et al.
Publicado: (2023)

Gene Expression and DNA Methylation Status of Glutathione S-Transferase Mu1 and Mu5 in Urothelial Carcinoma
por: Wang, Shou-Chieh, et al.
Publicado: (2016)

The lncRNA CASC2 Modulates Hepatocellular Carcinoma Cell Sensitivity and Resistance to TRAIL Through Apoptotic and Non-Apoptotic Signaling
por: Sun, Jichun, et al.
Publicado: (2022)

Dose-related immunomodulatory effects of recombinant TRAIL in the tumor immune microenvironment
por: Wang, Xupu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jdaq79oa8gelpllpbc734k03jh